FDA has approved MSD's KEYTRUDA (pembrolizumab) plus platinum- and fluoropyrimidine-based chemotherapy
Therapy used for the treatment of certain patients with locally advanced or metastatic esophageal or gastroesophageal junction carcinoma
Therapy used for the treatment of certain patients with locally advanced or metastatic esophageal or gastroesophageal junction carcinoma
Twist Biopharma will leverage its biologics and proprietary discovery capabilities to find novel GPCR target-specific antibodies for Kyowa Kirin
The launch extends the Polar BioPharma Lifecycle Management (BPLM) platform with best practices in preclinical drug qualification
Innovative qPCR platform simplifies molecular diagnostic workflows for infectious disease, oncology and COVID-19 testing
The assay has the ability to sequence and surveil evolution of virus mutations over time and geography
Artel MVS as a Tool For Measuring Liquid Mixing Efficacy in Microplates
In this on-demand webinar, we look at ways to improve time to result in critical pathways such as sepsis
This study offers new insights into high grade serous ovarian cancer that have the potential to make an impact in how patients are treated in the future
This partnership aims to offer an accelerated route to market rapid test technologies
Lenco Diagnostic Laboratories among first to offer Beckman Coulter’s semi-quantitative antibody test